Clinical Trials Browser

Phase 3 × Nasopharyngeal Carcinoma × Immune Checkpoint Inhibitors × Clear all

NCT05941741 2026-03-18

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Phase 3 Recruiting

Nasopharyngeal Carcinoma

NCT04907370 2025-07-16

DIAMOND

Phase 3 Active not recruiting

Nasopharyngeal Carcinoma